Top 10 Findings: Lithium, Lumateperone, and Lavender
The Carlat Psychiatry Podcast
00:00
Augmenting Antidepressants: Exploring Lumateperone and Other Strategies
This chapter reviews a recent clinical trial on lumateperone's effectiveness in augmenting treatment for major depression in unresponsive patients. It compares lumateperone's performance with other FDA-approved options, highlighting aripiprazole as the leading choice based on its effect size and extensive research support.
Transcript
Play full episode
